A study by Pauli and colleagues in this issue of
Cancer Discovery describes the creation of a precision cancer platform for patients with advanced disease, integrating DNA sequencing of patient tumors with the generation of patient - derived organoids and xenog
Cancer Discovery describes the creation of a
precision cancer platform for patients with advanced disease, integrating DNA sequencing of patient tumors with the generation of patient - derived organoids and xenog
cancer platform for patients with advanced disease, integrating DNA sequencing of patient tumors with the
generation of patient - derived organoids and xenografts.